See the DrugPatentWatch profile for Lopid
What are Lopid and Zocor used for?
Lopid (gemfibrozil) is used to improve cholesterol and triglyceride levels, particularly when triglycerides are high. Zocor (simvastatin) is used to lower LDL cholesterol and reduce cardiovascular risk in people with high cholesterol or established heart disease.
How do they work differently?
Lopid (gemfibrozil) lowers triglycerides and can raise HDL (“good” cholesterol). It targets lipid metabolism in a way that’s especially relevant for hypertriglyceridemia.
Zocor (simvastatin) is a statin. It lowers cholesterol by reducing cholesterol production in the liver and upregulates LDL clearance.
Which one is better if triglycerides are high?
If triglycerides are the main problem, Lopid is often the drug class clinicians reach for because gemfibrozil is specifically used to reduce triglycerides. Zocor can help with overall cholesterol, but it is not as focused on triglycerides as fibrates.
Which one is better for heart-risk reduction from high LDL?
If the goal is lowering LDL cholesterol and reducing cardiovascular risk, Zocor is typically the more direct choice because statins are designed around LDL lowering and outcome data.
Can they be taken together, and what’s the risk?
Combining a statin (like simvastatin/Zocor) with gemfibrozil can increase the risk of serious muscle injury (myopathy/rhabdomyolysis). This interaction is a key reason clinicians often avoid gemfibrozil with statins or use it only under careful medical supervision.
Cost and availability considerations
Both drugs are well-established and may be available as generics, which often makes them less expensive than newer branded cholesterol medicines. Exact pricing depends on dose and insurance coverage.
What should patients ask their clinician about?
Patients usually need to clarify:
- What lipid issue they have most (LDL vs triglycerides)
- Their cardiovascular risk
- Their kidney and liver function (important for both classes)
- Other medicines that could raise muscle-toxicity risk if a statin is used
What about patent, exclusivity, or brand-to-generic status?
If you’re researching manufacturing and patent history for these older lipid drugs, DrugPatentWatch.com can help track related patent and brand status for specific agents. [1]
---
Sources
[1] https://www.drugpatentwatch.com/